Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Coding and noncoding drivers of mantle cell lymphoma identified through exome and genome sequencing
Prasath Pararajalingam, Krysta M. Coyle, Sarah E. Arthur, et al.
Blood (2020) Vol. 136, Iss. 5, pp. 572-584
Open Access | Times Cited: 52

Showing 1-25 of 52 citing articles:

Genomic profiling for clinical decision making in lymphoid neoplasms
Laurence de Leval, Ash A. Alizadeh, P. Leif Bergsagel, et al.
Blood (2022) Vol. 140, Iss. 21, pp. 2193-2227
Open Access | Times Cited: 109
Mantle cell lymphoma in 2022—A comprehensive update on molecular pathogenesis, risk stratification, clinical approach, and current and novel treatments
Preetesh Jain, Michael Wang
American Journal of Hematology (2022) Vol. 97, Iss. 5, pp. 638-656
Closed Access | Times Cited: 95
B-cell non-Hodgkin lymphomas
Elisabeth Silkenstedt, Gilles Salles, Elı́as Campo, et al.
The Lancet (2024) Vol. 403, Iss. 10438, pp. 1791-1807
Closed Access | Times Cited: 17
Genetic mutations and features of mantle cell lymphoma: a systematic review and meta-analysis
Holly A. Hill, Xinyue Qi, Preetesh Jain, et al.
Blood Advances (2020) Vol. 4, Iss. 13, pp. 2927-2938
Open Access | Times Cited: 92
Splicing factor mutations in hematologic malignancies
Sisi Chen, Salima Benbarche, Omar Abdel‐Wahab
Blood (2021) Vol. 138, Iss. 8, pp. 599-612
Open Access | Times Cited: 66
Genomic and transcriptomic profiling reveals distinct molecular subsets associated with outcomes in mantle cell lymphoma
Shuhua Yi, Yuting Yan, Meiling Jin, et al.
Journal of Clinical Investigation (2021) Vol. 132, Iss. 3
Open Access | Times Cited: 64
Mantle cell lymphoma – advances in molecular biology, prognostication and treatment approaches
Elisabeth Silkenstedt, Kim Linton, Martin Dreyling
British Journal of Haematology (2021) Vol. 195, Iss. 2, pp. 162-173
Open Access | Times Cited: 55
HNRNPH1 destabilizes the G-quadruplex structures formed by G-rich RNA sequences that regulate the alternative splicing of an oncogenic fusion transcript
Tam Vo, Tayvia Brownmiller, Katherine L. Hall, et al.
Nucleic Acids Research (2022) Vol. 50, Iss. 11, pp. 6474-6496
Open Access | Times Cited: 27
Emerging Therapies in CLL in the Era of Precision Medicine
Prajish Iyer, Lili Wang
Cancers (2023) Vol. 15, Iss. 5, pp. 1583-1583
Open Access | Times Cited: 16
The HNRNPF/H RNA binding proteins and disease
Tayvia Brownmiller, Natasha J. Caplen
Wiley Interdisciplinary Reviews - RNA (2023) Vol. 14, Iss. 5
Open Access | Times Cited: 15
High-Risk Mantle Cell Lymphoma: Definition, Current Challenges, and Management
Preetesh Jain, Martin Dreyling, John F. Seymour, et al.
Journal of Clinical Oncology (2020) Vol. 38, Iss. 36, pp. 4302-4316
Closed Access | Times Cited: 39
Early relapse identifies MCL patients with inferior survival after intensive or less intensive frontline therapy
David A. Bond, Jeffrey M. Switchenko, Diego Villa, et al.
Blood Advances (2021) Vol. 5, Iss. 23, pp. 5179-5189
Open Access | Times Cited: 30
Biological relevance of alternative splicing in hematologic malignancies
Monika Szelest, Krzysztof Giannopoulos
Molecular Medicine (2024) Vol. 30, Iss. 1
Open Access | Times Cited: 4
Blastoid Mantle Cell Lymphoma
Preetesh Jain, Michael Wang
Hematology/Oncology Clinics of North America (2020) Vol. 34, Iss. 5, pp. 941-956
Closed Access | Times Cited: 30
Exploiting the fibroblast growth factor receptor-1 vulnerability to therapeutically restrict the MYC-EZH2-CDKN1C axis-driven proliferation in Mantle cell lymphoma
Anuvrat Sircar, Satishkumar Singh, Zijun Y. Xu‐Monette, et al.
Leukemia (2023) Vol. 37, Iss. 10, pp. 2094-2106
Open Access | Times Cited: 10
Biological and Clinical Determinants Shaping Heterogeneity in Mantle Cell Lymphoma
Cristina López, Elisabeth Silkenstedt, Martin Dreyling, et al.
Blood Advances (2024) Vol. 8, Iss. 14, pp. 3652-3664
Open Access | Times Cited: 3
Circulating tumor DNA in lymphoma: technologies and applications
Lina Fu, Xue‐Rong Zhou, Xiaoyu Zhang, et al.
Journal of Hematology & Oncology (2025) Vol. 18, Iss. 1
Open Access
Expression patterns and prognostic potential of circular RNAs in mantle cell lymphoma: a study of younger patients from the MCL2 and MCL3 clinical trials
Mette Dahl, Simon Husby, Christian Winther Eskelund, et al.
Leukemia (2021) Vol. 36, Iss. 1, pp. 177-188
Closed Access | Times Cited: 22
CD5 Gene Signature Identifies Diffuse Large B-Cell Lymphomas Sensitive to Brutonʼs Tyrosine Kinase Inhibition
Alan Cooper, Sravya Tumuluru, Kyle Kissick, et al.
Journal of Clinical Oncology (2023) Vol. 42, Iss. 4, pp. 467-480
Closed Access | Times Cited: 9
Sequencing‐based analysis of clonal evolution of 25 mantle cell lymphoma patients at diagnosis and after failure of standard immunochemotherapy
Jana Karolová, Dmitry Kazantsev, Michael Svatoň, et al.
American Journal of Hematology (2023) Vol. 98, Iss. 10, pp. 1627-1636
Open Access | Times Cited: 8
Towards precision medicine in lymphoid malignancies
Marco M. Bühler, José I. Martín‐Subero, Qiang Pan‐Hammarström, et al.
Journal of Internal Medicine (2021) Vol. 292, Iss. 2, pp. 221-242
Open Access | Times Cited: 19
Epigenomic Characterization of Lymphoid Neoplasms
Martí Duran‐Ferrer, José I. Martín‐Subero
Annual Review of Pathology Mechanisms of Disease (2023) Vol. 19, Iss. 1, pp. 371-396
Closed Access | Times Cited: 7
Large B-cell lymphomas with CCND1 rearrangement have different immunoglobulin gene breakpoints and genomic profile than mantle cell lymphoma
Ece Özoğul, Anna Montaner, Melina Pol, et al.
Blood Cancer Journal (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
Precision diagnostics in lymphomas – Recent developments and future directions
Larry Mansouri, Birna Þorvaldsdóttir, Stamatia Laidou, et al.
Seminars in Cancer Biology (2021) Vol. 84, pp. 170-183
Open Access | Times Cited: 14
Recent advances in upper gastrointestinal lymphomas: molecular updates and diagnostic implications
Periklis Foukas, Bettina Bisig, Laurence de Leval
Histopathology (2020) Vol. 78, Iss. 1, pp. 187-214
Open Access | Times Cited: 14
Page 1 - Next Page

Scroll to top